Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?

Show other versions (1)

OBJECTIVE: The frequency and the degree of recovery of anterior pituitary hormone deficits in patients with macroprolactinoma responsive to cabergoline are not clear. Our aim was to evaluate pituitary function in these patients with particular reference to an assessment of the possible restoration...

Full description

Bibliographic Details
Main Authors:	Karavitaki, N, Dobrescu, R, Byrne, J, Grossman, AB, Wass, J
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Does hypopituitarism recover when macroprolactinomas are treated with cabergoline?
by: Karavitaki, N, et al.
Published: (2013)

Prospective Assessment of Pituitary Function in Patients with Macroprolactinoma Treated with Cabergoline.
by: Karavitaki, N, et al.
Published: (2010)

Radiation-induced hypopituitarism.
by: Fernandez, A, et al.
Published: (2009)

The outcome of macroprolactinomas resistant to dopamine agonists
by: Coculescu, M, et al.
Published: (2005)

Valvular heart disease and the use of cabergoline for the treatment of prolactinoma.
by: Herring, N, et al.
Published: (2009)

Hypopituitarism oddities: craniopharyngiomas.
by: Karavitaki, N
Published: (2007)

The modern management of macroprolactinomas.
by: Grossman, A
Published: (1991)

Nonsurgical cerebrospinal fluid rhinorrhea in invasive macroprolactinoma: incidence, radiological, and clinicopathological features.
by: Suliman, S, et al.
Published: (2007)

A case of macroprolactinoma encasing an internal carotid artery aneurysm, presenting as pituitary apoplexy.
by: Soni, A, et al.
Published: (2008)

Premature mortality and hypopituitarism.
by: Erfurth, E, et al.
Published: (2001)

Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma.
by: Barber, T, et al.
Published: (2011)

ENHANCING HYPOTHALAMIC-LESIONS SHOWN ON HIGH-RESOLUTION COMPUTERIZED-TOMOGRAPHY IN PATIENTS WITH IDIOPATHIC HYPOPITUITARISM
by: Charlesworth, M, et al.
Published: (1986)

ENHANCING HYPOTHALAMIC-LESIONS SHOWN ON HIGH-RESOLUTION COMPUTERIZED-TOMOGRAPHY IN PATIENTS WITH IDIOPATHIC HYPOPITUITARISM
by: Charlesworth, M, et al.
Published: (1986)

Hypophyseal Wegener's granulomatosis presenting by visual field constriction without hypopituitarism.
by: Pereira, E, et al.
Published: (2013)

Hypophyseal Wegener's granulomatosis presenting by visual field constriction without hypopituitarism
by: Pereira, E, et al.
Published: (2013)

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea
by: Ismail, I.S., et al.
Published: (1994)

Association between premature mortality and hypopituitarism
by: Tomlinson, J, et al.
Published: (2001)

HYPOPITUITARISM IN CHILDREN - GRF-40 PROMOTES GH SECRETION AND CRF-41 ACTH-SECRETION
by: Grossman, A, et al.
Published: (1984)

Premature mortality and hypopituitarism - Authors' reply
by: Stewart, P, et al.
Published: (2001)

Macroprolactinomas and Nonfunctioning Pituitary Adenomas and Pregnancy Outcomes.
by: Lambert, K, et al.
Published: (2017)

Macroprolactinomas and nonfunctioning pituitary adenomas and pregnancy outcomes
by: Lambert, K, et al.
Published: (2017)

Can we ever stop imaging in surgically treated and radiotherapy-naive patients with non-functioning pituitary adenoma?
by: Reddy, R, et al.
Published: (2011)

Addisonian-like crisis in congenital hypopituitarism and cholestatic jaundice
by: Lee, Way Seah, et al.
Published: (2003)

The efficacy and tolerability of long-term cabergoline therapy in hyperprolactinaemic disorders an open, uncontrolled, multicentre study
by: Ismail, I.S., et al.
Published: (1993)

Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group.
by: Tomlinson, J, et al.
Published: (2001)

Outcome in surgically treated Rathke's cleft cysts: long-term monitoring needed.
by: Trifanescu, R, et al.
Published: (2011)

Disconnection hyperprolactinaemia in nonadenomatous sellar/parasellar lesions practically never exceeds 2000 mU/l.
by: Korevaar, T, et al.
Published: (2012)

'It's not over when it's over': persistent neurobiological abnormalities in recovered depressed patients.
by: Bhagwagar, Z, et al.
Published: (2008)

Hypopituitarism following envenoming by Russell's vipers (Daboia siamensis and D. russelii) resembling Sheehan's syndrome: first case report from Sri Lanka, a review of the literature and recommendations for endocrine management.
by: Antonypillai, C, et al.
Published: (2011)

Rathke's cleft cysts.
by: Trifanescu, R, et al.
Published: (2012)

Recovering from service failure: does satisfaction fortify brand trust?
by: Abd Rashid, Muhammad Hafiz, et al.
Published: (2014)

Growth hormone replacement in patients with non-functioning pituitary adenoma treated solely by surgery is not associated with increased risk of tumour recurrence.
by: Arnold, J, et al.
Published: (2008)

When to discontinue treatment of prolactinoma?
by: Wass, J
Published: (2006)

GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
by: Arnold, JR, et al.
Published: (2009)

Producing and understanding conditionals: When does it happen and why does it matter?
by: Badger, J, et al.
Published: (2018)

Improving the effectiveness of stroke prevention: when to treat and who to treat
by: Rothwell, P
Published: (2004)

GH replacement does not increase the risk of recurrence in patients with craniopharyngioma.
by: Karavitaki, N, et al.
Published: (2006)

When we treat glaucoma suspect ?
by: , Fifin Luthfia Rahmi
Published: (2010)

When does third-degree price discrimination reduce social welfare, and when does it raise it?
by: Cowan, S
Published: (2008)

When does third-degree price discrimination reduce social welfare, and when does it raise it?
by: Cowan, S, et al.
Published: (2008)